These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29606609)

  • 21. Notice regarding section 602 of the Veterans Health Care Act of 1992 inclusion of outpatient hospital facilities--PHS. Notice.
    Fed Regist; 1994 Jun; 59(107):29300-1. PubMed ID: 10135125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
    Werling K; Abraham S; Strelec J
    Health Care Law Mon; 2007 Aug; ():3-12. PubMed ID: 17955590
    [No Abstract]   [Full Text] [Related]  

  • 23. Hospital Prices for Physician-Administered Drugs for Patients with Private Insurance.
    Robinson JC; Whaley C; Dhruva SS
    N Engl J Med; 2024 Jan; 390(4):338-345. PubMed ID: 38265645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncology Transactions and the 340B Drug Pricing Program.
    Warren A; Shankar A
    J Oncol Pract; 2013 Mar; 9(2):89-91. PubMed ID: 23814516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 340B program presents opportunities--and challenges.
    Keough CL; Webster SA
    Healthc Financ Manage; 2009 Nov; 63(11):42-4, 46, 48. PubMed ID: 19891397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
    Werling K; Abraham S; Strelec J
    J Health Care Finance; 2007; 34(2):57-70. PubMed ID: 18972994
    [No Abstract]   [Full Text] [Related]  

  • 27. Implementation of a $4 generic drug program in a 340B pharmacy.
    Bright DR; Adams AJ; Akala FO; Lengel AJ; Martin SJ; Powers MF
    Am J Health Syst Pharm; 2010 Jun; 67(11):929-31. PubMed ID: 20484217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HRSA's failures, drug overcharges lead to overhaul of 340B agency.
    Young D
    Am J Health Syst Pharm; 2004 Sep; 61(17):1742, 1745, 1750. PubMed ID: 15462240
    [No Abstract]   [Full Text] [Related]  

  • 29. Who benefits from drug discounts? Drugmakers, hospitals battle over indigent-care program.
    Lee J
    Mod Healthc; 2013 Jul; 43(28):8-9. PubMed ID: 24044228
    [No Abstract]   [Full Text] [Related]  

  • 30. Notice regarding HRSA grant requirement--participation in the 340B drug pricing program--HRSA. Notice.
    Fed Regist; 1998 Oct; 63(204):56656-8. PubMed ID: 10187117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of patient assistance programs and the 340B Drug Pricing Program on medication cost.
    Castellon YM; Bazargan-Hejazi S; Masatsugu M; Contreras R
    Am J Manag Care; 2014 Feb; 20(2):146-50. PubMed ID: 24738532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges for Managed Care from 340B Contract Pharmacies.
    Fein AJ
    J Manag Care Spec Pharm; 2016 Mar; 22(3):197-203. PubMed ID: 27003548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risks to the 340B Drug Pricing Program.
    Daifotis AG
    JAMA; 2022 Sep; 328(11):1109. PubMed ID: 36125477
    [No Abstract]   [Full Text] [Related]  

  • 34. Tips for preparing for a 340B integrity audit.
    Wood W; Jorgenson J; Kelly W
    Healthc Financ Manage; 2012 Dec; 66(12):50-2. PubMed ID: 23252228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Federal court judge blocks 340B orphan drug exclusion rule.
    Benmaamar R
    Lancet Oncol; 2014 Jul; 15(8):e313. PubMed ID: 25121181
    [No Abstract]   [Full Text] [Related]  

  • 36. Fast track to 340B.
    Gricius RF; Wong D
    Healthc Financ Manage; 2016 Jan; 70(1):56-62. PubMed ID: 26863836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B.
    Han D
    J Health Econ; 2023 May; 89():102754. PubMed ID: 37030057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 340B Drug Pricing Program and hospital provision of uncompensated care.
    Desai SM; McWilliams JM
    Am J Manag Care; 2021 Oct; 27(10):432-437. PubMed ID: 34668672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community Health Center 340B Program: A Qualitative Study of the Experiences of Patients with Diabetes.
    Wagner AA; Whitner JB; Williams AC; Hirt KL; Miracle TL; Valentino AS
    Innov Pharm; 2023; 14(3):. PubMed ID: 38487386
    [No Abstract]   [Full Text] [Related]  

  • 40. Final notice regarding section 602 of the Veterans Health Care Act of 1992 duplicate discounts and rebates on drug purchases--HRSA. Final notice.
    Fed Regist; 1993 Jun; 58(119):34058-9. PubMed ID: 10126861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.